Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | OGG1 | O15527 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.47 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.46 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28178041 | 0.98 | HTT (0.49) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL29175021 | 0.98 | HTT (0.49) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL14841055 | 0.94 | HTT (0.47) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL27538515 | 0.91 | GPR84 (0.51) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL3717591 | 0.91 | HTT (0.50) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL29206847 | 0.90 | HTT (0.47) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL5251402 | 0.90 | HTT (0.47) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| Propene SCHEMBL27755920 | 0.90 | BTN3A1 (0.49) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL25229090 | 0.89 | HTT (0.49) | L3MBTL1KMT2AGPR84HTTMEN1 | |
| SCHEMBL25259138 | 0.89 | HTT (0.46) | L3MBTL1KMT2AGPR84HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136918-A | Method for preparing 4- (2, 2-diaryl vinyl) thiophosphorus/phosphonate | 岳阳凯茂化工材料有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-118878452-B | Isoindolinone derived unsaturated imine compound, synthesis method thereof and application thereof in anti-tumor activity | 徐州市第一人民医院 | 2025-01-24 | — | — | CN | claimed |
| CN-118955508-A | Alpha-indolylpyrrolo [1,2-a ] indole derivative and preparation method thereof | 浙江大学 | 2024-11-15 | — | — | CN | claimed |
| CN-118878452-A | Isoindolinone derived unsaturated imine compound, synthesis method thereof and application thereof in anti-tumor activity | 徐州市第一人民医院 | 2024-11-01 | — | — | CN | claimed |
| CN-113109406-B | Method for constructing electrochemiluminescence aptamer sensor for omethoate detection | 江苏大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115677451-A | Method for preparing trans-dibenzyl ethylene compound | 中国科学院大连化学物理研究所 | 2023-02-03 | — | — | CN | claimed |
| CN-113173925-B | Benzoxoepinoindole derivative and preparation method thereof | 浙江大学 | 2022-11-11 | — | — | CN | claimed |
| US-11440871-B2 | Zuclomiphene salts and crystalline forms thereof | APOTEX INC. (CA) | 2022-09-13 | — | — | US | claimed |
| CN-113993855-A | Method for synthesizing 5-hydroxymethylfurfural | IFP 新能源公司 | 2022-01-28 | — | — | CN | claimed |
| CN-110590835-B | Method for preparing 2-iodo-1-phosphoryl substituted alkane compound by high-efficiency double functionalization of olefin | 湖南理工学院 | 2021-09-07 | — | — | CN | claimed |
| EP-2017271-A1 | Process for the preparation of escitalopram | Aurobindo Pharma Limited (IN) | 2009-01-21 | — | — | EP | claimed |
| US-20090018351-A1 | PREPARATION OF ESCITALOPRAM | DR. REDDY'S LABORATORIES, INC. (US) | 2009-01-15 | — | — | US | claimed |
| EP-1706394-A4 | PREPARATION OF ESCITALOPRAM | REDDYS LAB INC DR (US) | 2008-10-22 | — | — | EP | claimed |
| EP-1877394-A1 | PROCESS FOR THE PREPARATION OF ESCITALOPRAM OR ITS ACID ADDITION SALTS | Jubilant Organosys Limited (IN) | 2008-01-16 | — | — | EP | claimed |
| WO-2006106531-A1 | PROCESS FOR THE PREPARATION OF ESCITALOPRAM OR ITS ACID ADDITION SALTS | JUBILANT ORGANOSYS LTD (IN) | 2006-10-12 | — | — | WO | claimed |
| EP-1706394-A1 | PREPARATION OF ESCITALOPRAM | Dr. Reddy's Laboratories, Inc. (US) | 2006-10-04 | — | — | EP | claimed |
| US-20050154051-A1 | Method for the preparation of escitalopram | H. LUNDBECK A/S (DK) | 2005-07-14 | — | — | US | claimed |
| WO-2005047274-A1 | PREPARATION OF ESCITALOPRAM | DR. REDDY'S LABORATORIES, INC. (US) | 2005-05-26 | — | — | WO | claimed |
| EP-1458701-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. Lundbeck A/S (DK) | 2004-09-22 | — | — | EP | claimed |
| WO-2003051861-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2003-06-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11440871-B2 | Zuclomiphene salts and crystalline forms thereof | ZP1, ZYX, ALPP | L3MBTL1 915/4885KMT2A 1497/4885GPR84 2229/4885 |
| US-20050154051-A1 | Method for the preparation of escitalopram | SLC6A4, TPH2, SLC6A3 | L3MBTL1 4350/4885KMT2A 1280/4885GPR84 3802/4885 |
| US-20090018351-A1 | PREPARATION OF ESCITALOPRAM | HTR4, SLC6A4, HTR5A | L3MBTL1 3278/4885KMT2A 630/4885GPR84 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.